The Combined Effect of the Systemic Immune-Inflammation Index and Aortic Valve Calcification on Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease
Journal of Inflammation Research · 2024-11 · Volume 17 · 8375-8384
DOI: 10.2147/jir.s493735 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inflammation Research, 2024-11. Verfasst von Miaomiao Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Chest Hospital of Zhengzhou University, Zhengzhou, 450008, People's Republic of China. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Background
The combined effect of systemic immune-inflammation index (SII) and aortic valve calcification (AVC) on the risk of major adverse cardiovascular events (MACE) in patients with coronary heart disease (CHD) remains unclear. This study aimed to investigate their combined association with MACE in CHD.
Methods
This retrospective cohort study included 846 CHD patients. SII was calculated as platelet count × neutrophil count / lymphocyte count, and AVC status was determined by echocardiography. Patients were divided into four groups based on median SII and AVC presence: Low SII + AVC (-), High SII + AVC (-), Low SII + AVC (+), and High SII + AVC (+). Cox regression, subgroup and sensitivity analyses assessed the association between SII + AVC and MACE.
Results
Multivariate Cox regression revealed that, compared to the Low SII + AVC (-), MACE risk increased 6.542-fold in the High SII + AVC (+) group and 1.605-fold in the High SII + AVC (-) group (P < 0.05). Subgroup analysis indicated that, compared to the Low SII + AVC (-), MACE risk was significantly elevated in the High SII + AVC (-) group for patients over 60, both genders, with hypertension, hyperlipidemia, or without diabetes (P < 0.05). In the Low SII + AVC (+) group, MACE risk was elevated only in males (P < 0.05). The High SII + AVC (+) group had increased MACE risk in all subgroups except those with diabetes (P < 0.05). After excluding patients with estimated glomerular filtration rate < 60 mL/min/1.73m², the high SII + AVC (+) group remained significantly associated with increased MACE risk (P = 0.001), as did the High SII + AVC (-) group (P = 0.031).
Conclusion
The combination of SII and AVC is significantly associated with MACE risk in patients with CHD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Chest Hospital of Zhengzhou University, Zhengzhou, 450008, People's Republic of China.
- Department of Cardiology, Henan Province Chest Hospital, Zhengzhou, 450008, People's Republic of China.
- Department of Pediatrics, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, People's Republic of China.
- Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, People's Republic of China.
ORCID-Profile: Zhenwei Wang
Zitieren
APA
Li, M., Li, M., Wang, Z., & Zhang, Y. (2024). The Combined Effect of the Systemic Immune-Inflammation Index and Aortic Valve Calcification on Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease. Journal of Inflammation Research, Volume 17, 8375-8384. https://doi.org/10.2147/jir.s493735
Vancouver
Li M, Li M, Wang Z, Zhang Y. The Combined Effect of the Systemic Immune-Inflammation Index and Aortic Valve Calcification on Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease. Journal of Inflammation Research. 2024;Volume 17:8375-8384. doi:10.2147/jir.s493735
BibTeX
@article{Li2024,
author = {Li, Miaomiao and Li, Mengchun and Wang, Zhenwei and Zhang, Yongbo},
title = {The Combined Effect of the Systemic Immune-Inflammation Index and Aortic Valve Calcification on Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease},
journal = {Journal of Inflammation Research},
year = {2024},
volume = {Volume 17},
pages = {8375--8384},
doi = {10.2147/jir.s493735}
}
EUVIMED